Publications 2024

Raju SC, Molinaro A, Awoyemi A, Jørgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegård KT, Halvorsen B, Kristiansen K, Hov JR, Trøseid M (2024)
Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity
Genome Med, 16 (1), 27
DOI 10.1186/s13073-024-01296-6, PubMed 38331891

Publications 2023

Gragnano F, Cao D, Pirondini L, Franzone A, Kim HS, von Scheidt M, Pettersen AR, Zhao Q, Woodward M, Chiarito M, McFadden EP, Park KW, Kastrati A, Seljeflot I, Zhu Y, Windecker S, Kang J, Schunkert H, Arnesen H, Bhatt DL, Steg PG, Calabrò P, Pocock S, Mehran R, Valgimigli M et al. (2023)
P2Y₁₂ Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
J Am Coll Cardiol, 82 (2), 89-105
DOI 10.1016/j.jacc.2023.04.051, PubMed 37407118

Myhre PL, Berge T, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Solheim S, Arnesen H, Seljeflot I, Tveit A (2023)
Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial
Clin Nutr, 42 (9), 1657-1660
DOI 10.1016/j.clnu.2023.07.002, PubMed 37515843

Nendl A, Raju SC, Broch K, Mayerhofer CCK, Holm K, Halvorsen B, Lappegård KT, Moscavitch S, Hov JR, Seljeflot I, Trøseid M, Awoyemi A (2023)
Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
Front Cardiovasc Med, 10, 1160030
DOI 10.3389/fcvm.2023.1160030, PubMed 37332580

Nilsen DWT, Myhre PL, Solheim S, Tveit SH, Kalstad AA, Laake K, Tveit A, Seljeflot I (2023)
Total Bilirubin Yields Prognostic Information Following a Myocardial Infarction in the Elderly
Antioxidants (Basel), 12 (6)
DOI 10.3390/antiox12061157, PubMed 37371887

Opstad TB, Alexander J, Aaseth J, Larsson A, Seljeflot I, Alehagen U (2023)
Increased SIRT1 Concentration Following Four Years of Selenium and Q₁₀ Intervention Associated with Reduced Cardiovascular Mortality at 10-Year Follow-Up-Sub-Study of a Previous Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial
Antioxidants (Basel), 12 (3)
DOI 10.3390/antiox12030759, PubMed 36979007

Opstad TB, Papotti B, Åkra S, Hansen CH, Braathen B, Tønnessen T, Solheim S, Seljeflot I (2023)
Sirtuin1, not NAMPT, possesses anti-inflammatory effects in epicardial, pericardial and subcutaneous adipose tissue in patients with CHD
J Transl Med, 21 (1), 644
DOI 10.1186/s12967-023-04518-4, PubMed 37730614

Papotti B, Opstad TB, Åkra S, Tønnessen T, Braathen B, Hansen CH, Arnesen H, Solheim S, Seljeflot I, Ronda N (2023)
Macrophage polarization markers in subcutaneous, pericardial, and epicardial adipose tissue are altered in patients with coronary heart disease
Front Cardiovasc Med, 10, 1055069
DOI 10.3389/fcvm.2023.1055069, PubMed 36937936

Simeunovic A, Brunborg C, Heier M, Seljeflot I, Dahl-Jørgensen K, Margeirsdottir HD (2023)
Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study
Atherosclerosis, 379, 117151
DOI 10.1016/j.atherosclerosis.2023.05.020, PubMed 37349194

Warlo EMK, Kalstad AA, Myhre PL, Solheim S, Arnesen H, Tveit A, Holme PA, Seljeflot I, Bratseth V (2023)
von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction
Res Pract Thromb Haemost, 7 (4), 100164
DOI 10.1016/j.rpth.2023.100164, PubMed 37255854

Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Ryan L, Bendz B, Hopp E, Kløw NE, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Amundsen BH, Damas JK, Kleveland O (2023)
Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
Open Heart, 10 (2)
DOI 10.1136/openhrt-2023-002301, PubMed 37591633

Publications 2022

Aukrust SG, Holte KB, Opstad TB, Seljeflot I, Berg TJ, Helseth R (2022)
NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease
Front Immunol, 12, 799539
DOI 10.3389/fimmu.2021.799539, PubMed 35069582

Aune SK, Bonnevie-Svendsen M, Nyborg C, Trøseid M, Seljeflot I, Hisdal J, Helseth R (2022)
Gut Leakage and Cardiac Biomarkers after Prolonged Strenuous Exercise
Med Sci Sports Exerc, 54 (9), 1476-1482
DOI 10.1249/MSS.0000000000002948, PubMed 35482788

Berge T, Myhre PL, Kalstad AA, Laake K, Tveit SH, Onarheim S, Solheim S, Seljeflot I, Arnesen H, Tveit A (2022)
Screen-Detected Atrial Fibrillation and "Micro-Atrial Fibrillation" and Risk of Cardiovascular Events after Myocardial Infarction in Elderly Patients
Cardiology, 148 (1), 72-77
DOI 10.1159/000528726, PubMed 36538900

Bratseth V, Nordeng J, Helseth R, Solheim S, Åkra S, Arnesen H, Chiva-Blanch G, Seljeflot I (2022)
Circulating Microvesicles in Association with the NLRP3 Inflammasome in Coronary Thrombi from STEMI Patients
Biomedicines, 10 (9)
DOI 10.3390/biomedicines10092196, PubMed 36140297

Cwikiel J, Fagerland MW, Wachtell K, Arnesen H, Seljeflot I, Flaa A (2022)
Exercise-induced change in circulating NT-proBNP could not distinguish between patients with and without coronary artery disease: the CADENCE study
Scand Cardiovasc J, 56 (1), 107-113
DOI 10.1080/14017431.2022.2075562, PubMed 35593516

Hansen CH, Cwikiel J, Bratseth V, Arnesen H, Flaa A, Seljeflot I (2022)
Effect of Revascularization on Exercise-Induced Changes in Cardiac and Prothrombotic Biomarkers in Patients with Coronary Artery Disease
Clin Appl Thromb Hemost, 28, 10760296221094029
DOI 10.1177/10760296221094029, PubMed 35437054

Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad L et al. (2022)
Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
EBioMedicine, 80, 104013
DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178

Kluge KE, Langseth MS, Andersen GØ, Halvorsen S, Opstad TB, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2022)
Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
Am Heart J Plus, 24, 100228
DOI 10.1016/j.ahjo.2022.100228, PubMed 38560636

Kluge KE, Seljeflot I, Arnesen H, Jensen T, Halvorsen S, Helseth R (2022)
Coagulation factors XI and XII as possible targets for anticoagulant therapy
Thromb Res, 214, 53-62
DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644

Kyte KH, Stensrud T, Berg TJ, Seljeflot I, Hisdal J (2022)
Vascular Function in Norwegian Female Elite Runners: A Cross-Sectional, Controlled Study
Sports (Basel), 10 (3)
DOI 10.3390/sports10030037, PubMed 35324646

Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
J Infect Dis, 225 (4), 661-674
DOI 10.1093/infdis/jiaa714, PubMed 33216130

Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
J Acquir Immune Defic Syndr, 89 (1), 77-86
DOI 10.1097/QAI.0000000000002817, PubMed 34878437

Molvaer AK, Iversen MM, Igland J, Peyrot M, Tell GS, Holte KB, Monnier VM, Seljeflot I, Berg TJ (2022)
Metabolic predictors of pain, fatigue, depression and quality of life in people with long-term type 1 diabetes-the Dialong study
Diabet Med, 40 (3), e15009
DOI 10.1111/dme.15009, PubMed 36398424

Myhre PL, Kalstad AA, Tveit SH, Laake K, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Solheim S, Arnesen H, Seljeflot I (2022)
Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial
J Intern Med, 291 (5), 637-647
DOI 10.1111/joim.13442, PubMed 34982486

Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
TIMP-1 expression in coronary thrombi associate with myocardial injury in ST-elevation myocardial infarction patients
Coron Artery Dis, 33 (6), 446-455
DOI 10.1097/MCA.0000000000001128, PubMed 35102064

Nordeng J, Solheim S, Åkra S, Schandiz H, Hoffmann P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
Gene expression of fibrinolytic markers in coronary thrombi
Thromb J, 20 (1), 23
DOI 10.1186/s12959-022-00383-1, PubMed 35488283

Opstad TB, Alexander J, Aaseth JO, Larsson A, Seljeflot I, Alehagen U (2022)
Selenium and Coenzyme Q₁₀ Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial
Nutrients, 14 (16)
DOI 10.3390/nu14163346, PubMed 36014852

Opstad TB, Nordeng J, Pettersen AR, Åkra S, Bratseth V, Zaidi H, Helseth R, Solheim S, Seljeflot I (2022)
The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome
J Immunol Res, 2022, 2366695
DOI 10.1155/2022/2366695, PubMed 36582742

Opstad TB, Solheim S, Pettersen AR, Kalstad AA, Arnesen H, Seljeflot I (2022)
TERT and TET2 Genetic Variants Affect Leukocyte Telomere Length and Clinical Outcome in Coronary Artery Disease Patients-A Possible Link to Clonal Hematopoiesis
Biomedicines, 10 (8)
DOI 10.3390/biomedicines10082027, PubMed 36009574

Warlo EMK, Bratseth V, Pettersen AR, Holme PA, Arnesen H, Seljeflot I, Opstad TB (2022)
Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events
Clin Appl Thromb Hemost, 28, 10760296221141893
DOI 10.1177/10760296221141893, PubMed 36474435

Zaidi H, Aksnes T, Åkra S, Eggesbø HB, Byrkjeland R, Seljeflot I, Opstad TB (2022)
Abdominal Adipose Tissue Associates With Adiponectin and TNFα in Middle-Aged Healthy Men
Front Endocrinol (Lausanne), 13, 874977
DOI 10.3389/fendo.2022.874977, PubMed 35872989

Åkra S, Seljeflot I, Braathen B, Bratseth V, Hansen CH, Arnesen H, Tønnessen T, Solheim S (2022)
The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery
Atheroscler Plus, 48, 47-54
DOI 10.1016/j.athplu.2022.03.005, PubMed 36644557

Publications 2021

Aune SK, Byrkjeland R, Solheim S, Arnesen H, Trøseid M, Awoyemi A, Seljeflot I, Helseth R (2021)
Gut related inflammation and cardiorespiratory fitness in patients with CAD and type 2 diabetes: a sub-study of a randomized controlled trial on exercise training
Diabetol Metab Syndr, 13 (1), 36
DOI 10.1186/s13098-021-00655-2, PubMed 33794977

Aune SK, Cwikiel J, Flaa A, Arnesen H, Solheim S, Awoyemi A, Trøseid M, Seljeflot I, Helseth R (2021)
Gut Leakage Markers in Response to Strenuous Exercise in Patients with Suspected Coronary Artery Disease
Cells, 10 (9)
DOI 10.3390/cells10092193, PubMed 34571843

Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
EBioMedicine, 70, 103511
DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947

Broch K, Anstensrud AK, Woxholt S, Sharma K, Tøllefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Bendz C, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2021)
Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
J Am Coll Cardiol, 77 (15), 1845-1855
DOI 10.1016/j.jacc.2021.02.049, PubMed 33858620

Chaban V, Nakstad ER, Stær-Jensen H, Schjalm C, Seljeflot I, Vaage J, Lundqvist C, Benth JŠ, Sunde K, Mollnes TE, Andersen GØ, Pischke SE (2021)
Complement activation is associated with poor outcome after out-of-hospital cardiac arrest
Resuscitation, 166, 129-136
DOI 10.1016/j.resuscitation.2021.05.038, PubMed 34126135

Chiva-Blanch G, Bratseth V, Laake K, Arnesen H, Solheim S, Schmidt EB, Badimon L, Seljeflot I (2021)
One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction
Clin Nutr, 40 (12), 5674-5677
DOI 10.1016/j.clnu.2021.10.007, PubMed 34742136

Helseth R, Kleveland O, Ueland T, Wiseth R, Damas JK, Broch K, Michelsen A, Bendz B, Gullestad L, Aukrust P, Seljeflot I (2021)
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
Open Heart, 8 (1)
DOI 10.1136/openhrt-2020-001492, PubMed 33972404

Hoel H, Pettersen EM, Høiseth LØ, Mathiesen I, Seternes A, Seljeflot I, Hisdal J (2021)
Effects of intermittent negative pressure treatment on circulating vascular biomarkers in patients with intermittent claudication
Vasc Med, 26 (5), 489-496
DOI 10.1177/1358863X211007933, PubMed 33985385

Holm S, Kared H, Michelsen AE, Kong XY, Dahl TB, Schultz NH, Nyman TA, Fladeby C, Seljeflot I, Ueland T, Stensland M, Mjaaland S, Goll GL, Nissen-Meyer LS, Aukrust P, Skagen K, Gregersen I, Skjelland M, Holme PA, Munthe LA, Halvorsen B (2021)
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia
Eur Heart J, 42 (39), 4064-4072
DOI 10.1093/eurheartj/ehab506, PubMed 34405870

Kalstad AA, Myhre PL, Laake K, Opstad TB, Tveit A, Solheim S, Arnesen H, Seljeflot I (2021)
Biomarkers of ageing and cardiac remodeling are associated with atrial fibrillation
Scand Cardiovasc J, 55 (4), 213-219
DOI 10.1080/14017431.2021.1889653, PubMed 33650449

Myhre P, Seljeflot I, Arnesen H (2021)
[Myhre, Seljeflot and Arnesen respond]
Tidsskr Nor Laegeforen, 141 (10)
DOI 10.4045/tidsskr.21.0470, PubMed 34182730

Myhre PL, Seljeflot I, Arnesen H (2021)
Omega-3 supplements do not prevent cardiovascular disease
Tidsskr Nor Laegeforen, 141 (6)
DOI 10.4045/tidsskr.21.0033, PubMed 33876607

Myhre PL, Seljeflot I, Arnesen H (2021)
Omega-3 supplements do not prevent cardiovascular disease
Tidsskr. Nor. Laegeforen., 141 (6), 536-538

Nilsen DWT, Myhre PL, Kalstad A, Schmidt EB, Arnesen H, Seljeflot I (2021)
Serum Levels of Dihomo-Gamma (γ)-Linolenic Acid (DGLA) Are Inversely Associated with Linoleic Acid and Total Death in Elderly Patients with a Recent Myocardial Infarction
Nutrients, 13 (10)
DOI 10.3390/nu13103475, PubMed 34684479

Nordeng J, Schandiz H, Solheim S, Åkra S, Hoffman P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2021)
The Inflammasome Signaling Pathway Is Actively Regulated and Related to Myocardial Damage in Coronary Thrombi from Patients with STEMI
Mediators Inflamm, 2021, 5525917
DOI 10.1155/2021/5525917, PubMed 34135690

Nyborg C, Bonnevie-Svendsen M, Melsom HS, Melau J, Seljeflot I, Hisdal J (2021)
Reduced L-Arginine and L-Arginine-ADMA-Ratio, and Increased SDMA after Norseman Xtreme Triathlon
Sports (Basel), 9 (9)
DOI 10.3390/sports9090120, PubMed 34564325

Nyborg C, Melsom HS, Bonnevie-Svendsen M, Melau J, Seljeflot I, Hisdal J (2021)
Transient Reduction of FMD-Response and L-Arginine Accompanied by Increased Levels of E-Selectin, VCAM, and ICAM after Prolonged Strenuous Exercise
Sports (Basel), 9 (6)
DOI 10.3390/sports9060086, PubMed 34204566

Omland T, Prebensen C, Jonassen C, Svensson M, Berdal JE, Seljeflot I, Myhre PL (2021)
Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001884, PubMed 34933965

Opstad TB, Sundfør T, Tonstad S, Seljeflot I (2021)
Effect of intermittent and continuous caloric restriction on Sirtuin1 concentration depends on sex and body mass index
Nutr Metab Cardiovasc Dis, 31 (6), 1871-1878
DOI 10.1016/j.numecd.2021.03.005, PubMed 33975734

Saeed M, Tapia G, Ariansen I, Stene LC, Seljeflot I, Tell GS, Skrivarhaug T, Joner G (2021)
Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study
Diabetes Care, 44 (3), 810-816
DOI 10.2337/dc20-1712, PubMed 33408220

Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO (2021)
Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial
Sci Rep, 11 (1), 11593
DOI 10.1038/s41598-021-90976-z, PubMed 34078971

Thomas AM, Chaban V, Pischke SE, Orrem HL, Bosnes V, Sunde K, Seljeflot I, Lundqvist C, Nakstad ER, Andersen GØ, Schjalm C, Mollnes TE, Barratt-Due A (2021)
Complement ratios C3bc/C3 and sC5b-9/C5 do not increase the sensitivity of detecting acute complement activation systemically
Mol Immunol, 141, 273-279
DOI 10.1016/j.molimm.2021.11.016, PubMed 34906905

Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ (2021)
High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
Open Heart, 8 (2)
DOI 10.1136/openhrt-2021-001869, PubMed 34933964

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2021)
Adiponectin in relation to exercise and physical performance in patients with type 2 diabetes and coronary artery disease
Adipocyte, 10 (1), 612-620
DOI 10.1080/21623945.2021.1996699, PubMed 34779349

Publications 2020

Arnesen H, Myhre PL, Seljeflot I (2020)
Very Long Chain Marine n-3 Polyunsaturated Fatty Acids in Atherothrombotic Heart Disease. A Brief Review, with a Focus on Metabolic Effects
Nutrients, 12 (10)
DOI 10.3390/nu12103014, PubMed 33008057

Bratseth V, Margeirsdottir HD, Chiva-Blanch G, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Annexin V⁺ Microvesicles in Children and Adolescents with Type 1 Diabetes: A Prospective Cohort Study
J Diabetes Res, 2020, 7216863
DOI 10.1155/2020/7216863, PubMed 32309448

Bratseth V, Margeirsdottir HD, Heier M, Solheim S, Arnesen H, Dahl-Jørgensen K, Seljeflot I (2020)
Procoagulant activity in children and adolescents on intensive insulin therapy
Pediatr Diabetes, 21 (3), 496-504
DOI 10.1111/pedi.12978, PubMed 31943582

Hilde JM, Hisdal J, Skjørten I, Hansteen V, Melsom MN, Grøtta OJ, Småstuen MC, Seljeflot I, Arnesen H, Humerfelt S, Steine K (2020)
Left ventricular dysfunction in COPD without pulmonary hypertension
PLoS One, 15 (7), e0235075
DOI 10.1371/journal.pone.0235075, PubMed 32673327

Holte KB, Svanteson M, Hanssen KF, Sveen KA, Seljeflot I, Solheim S, Sell DR, Monnier VM, Berg TJ (2020)
Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study
PLoS One, 15 (5), e0233174
DOI 10.1371/journal.pone.0233174, PubMed 32401813

Kalstad AA, Myhre PL, Laake K, Tveit SH, Schmidt EB, Smith P, Nilsen DWT, Tveit A, Fagerland MW, Solheim S, Seljeflot I, Arnesen H, OMEMI Investigators (2020)
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial
Circulation, 143 (6), 528-539
DOI 10.1161/CIRCULATIONAHA.120.052209, PubMed 33191772

Kluge KE, Langseth MS, Bratseth V, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
Circulating levels of the terminal complement complex are associated with hypercoagulability in patients with stable coronary artery disease
Thromb Res, 196, 106-108
DOI 10.1016/j.thromres.2020.08.023, PubMed 32853976

Kluge KE, Langseth MS, Opstad TB, Pettersen AÅ, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2020)
Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease
Mediators Inflamm, 2020, 5080743
DOI 10.1155/2020/5080743, PubMed 32308555

Kummen M, Solberg OG, Storm-Larsen C, Holm K, Ragnarsson A, Trøseid M, Vestad B, Skårdal R, Yndestad A, Ueland T, Svardal A, Berge RK, Seljeflot I, Gullestad L, Karlsen TH, Aaberge L, Aukrust P, Hov JR (2020)
Rosuvastatin alters the genetic composition of the human gut microbiome
Sci Rep, 10 (1), 5397
DOI 10.1038/s41598-020-62261-y, PubMed 32214138

Langseth MS, Andersen GØ, Husebye T, Arnesen H, Zucknick M, Solheim S, Eritsland J, Seljeflot I, Opstad TB, Helseth R (2020)
Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
PLoS One, 15 (10), e0241333
DOI 10.1371/journal.pone.0241333, PubMed 33119664

Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
Sci Rep, 10 (1), 5007
DOI 10.1038/s41598-020-61971-7, PubMed 32193509

Mayerhofer CCK, Kummen M, Holm K, Broch K, Awoyemi A, Vestad B, Storm-Larsen C, Seljeflot I, Ueland T, Bohov P, Berge RK, Svardal A, Gullestad L, Yndestad A, Aukrust P, Hov JR, Trøseid M (2020)
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
ESC Heart Fail, 7 (2), 456-466
DOI 10.1002/ehf2.12596, PubMed 31978943

Nakstad ER, Stær-Jensen H, Wimmer H, Henriksen J, Alteheld LH, Reichenbach A, Drægni T, Šaltytė-Benth J, Wilson JA, Etholm L, Øijordsbakken M, Eritsland J, Seljeflot I, Jacobsen D, Andersen GØ, Lundqvist C, Sunde K (2020)
Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-Respiratory Arrest Study (NORCAST)
Resuscitation, 149, 170-179
DOI 10.1016/j.resuscitation.2019.12.031, PubMed 31926258

Opstad TB, Berg TJ, Holte KB, Arnesen H, Solheim S, Seljeflot I (2020)
Reduced leukocyte telomere lengths and sirtuin 1 gene expression in long-term survivors of type 1 diabetes: A Dialong substudy
J Diabetes Investig, 12 (7), 1183-1192
DOI 10.1111/jdi.13470, PubMed 33249778

Opstad TB, Kalstad AA, Holte KB, Berg TJ, Solheim S, Arnesen H, Seljeflot I (2020)
Shorter Leukocyte Telomere Lengths in Healthy Relatives of Patients with Coronary Heart Disease
Rejuvenation Res, 23 (4), 324-332
DOI 10.1089/rej.2019.2258, PubMed 31805818

Tveit SH, Cwikiel J, Myhre PL, Omland T, Berge E, Seljeflot I, Flaa A (2020)
Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise
Clin Biochem, 88, 23-29
DOI 10.1016/j.clinbiochem.2020.11.005, PubMed 33245871

Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2020)
Markers of remodeling in subcutaneous adipose tissue are strongly associated with overweight and insulin sensitivity in healthy non-obese men
Sci Rep, 10 (1), 14055
DOI 10.1038/s41598-020-71109-4, PubMed 32820223

Publications 2019

Anstensrud AK, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2019)
Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
Open Heart, 6 (2), e001108
DOI 10.1136/openhrt-2019-001108, PubMed 31673391

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2019)
Effects of dietary intervention and n-3 PUFA supplementation on markers of gut-related inflammation and their association with cardiovascular events in a high-risk population
Atherosclerosis, 286, 53-59
DOI 10.1016/j.atherosclerosis.2019.05.004, PubMed 31100620

Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA (2019)
Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study
Blood Press, 29 (2), 123-134
DOI 10.1080/08037051.2019.1684817, PubMed 31718316

Bratseth V, Chiva-Blanch G, Byrkjeland R, Solheim S, Arnesen H, Seljeflot I (2019)
Elevated levels of circulating microvesicles in coronary artery disease patients with type 2 diabetes and albuminuria: Effects of exercise training
Diab Vasc Dis Res, 16 (5), 431-439
DOI 10.1177/1479164119843094, PubMed 31023084

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2019)
High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population
Nutrients, 11 (5)
DOI 10.3390/nu11051114, PubMed 31109111

Cwikiel J, Seljeflot I, Fagerland MW, Wachtell K, Arnesen H, Berge E, Flaa A (2019)
High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease
Int J Cardiol, 287, 1-6
DOI 10.1016/j.ijcard.2019.04.019, PubMed 31006595

Ellingsen DG, Chashchin M, Seljeflot I, Berlinger B, Chashchin V, Stockfelt L, Thomassen Y (2019)
A study of atherothrombotic biomarkers in welders
Int Arch Occup Environ Health, 92 (7), 1023-1031
DOI 10.1007/s00420-019-01441-4, PubMed 31114965

Helseth R, Knudsen EC, Eritsland J, Opstad TB, Arnesen H, Andersen GØ, Seljeflot I (2019)
Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
BMC Cardiovasc Disord, 19 (1), 221
DOI 10.1186/s12872-019-1205-1, PubMed 31615411

Helseth R, Shetelig C, Andersen GØ, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I (2019)
Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
Mediators Inflamm, 2019, 7816491
DOI 10.1155/2019/7816491, PubMed 31772506

Kalstad AA, Tveit S, Myhre PL, Laake K, Opstad TB, Tveit A, Schmidt EB, Solheim S, Arnesen H, Seljeflot I (2019)
Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients
BMC Geriatr, 19 (1), 376
DOI 10.1186/s12877-019-1383-9, PubMed 31881852

Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
PLoS One, 14 (4), e0215640
DOI 10.1371/journal.pone.0215640, PubMed 31002684

Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
Atherosclerosis, 296, 74-82
DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625

Opstad TB, Kalstad AA, Pettersen AÅ, Arnesen H, Seljeflot I (2019)
Novel biomolecules of ageing, sex differences and potential underlying mechanisms of telomere shortening in coronary artery disease
Exp Gerontol, 119, 53-60
DOI 10.1016/j.exger.2019.01.020, PubMed 30684534

Solberg OG, Stavem K, Ragnarsson A, Beitnes JO, Skårdal R, Seljeflot I, Ueland T, Aukrust P, Gullestad L, Aaberge L (2019)
Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study
Catheter Cardiovasc Interv, 94 (5), 660-668
DOI 10.1002/ccd.28157, PubMed 30790446

Tveit SH, Myhre PL, Hoff NJS, Le TM, Seljeflot I, Røysland R, Høiseth AD, Røsjø H, Omland T (2019)
Superiority of high sensitivity cardiac troponin T vs. I for long-term prognostic value in patients with chest pain; data from the Akershus cardiac Examination (ACE) 3 study
Clin Biochem, 78, 10-17
DOI 10.1016/j.clinbiochem.2019.12.016, PubMed 31899280

Warlo EMK, Arnesen H, Seljeflot I (2019)
A brief review on resistance to P2Y₁₂ receptor antagonism in coronary artery disease
Thromb J, 17, 11
DOI 10.1186/s12959-019-0197-5, PubMed 31198410

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial
Diab Vasc Dis Res, 16 (4), 360-368
DOI 10.1177/1479164119836922, PubMed 30939905

Zaidi H, Byrkjeland R, Njerve IU, Åkra S, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2019)
Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial
Diabetol Metab Syndr, 11, 109
DOI 10.1186/s13098-019-0508-9, PubMed 31890043

Publications 2018

Awoyemi A, Trøseid M, Arnesen H, Solheim S, Seljeflot I (2018)
Markers of metabolic endotoxemia as related to metabolic syndrome in an elderly male population at high cardiovascular risk: a cross-sectional study
Diabetol Metab Syndr, 10, 59
DOI 10.1186/s13098-018-0360-3, PubMed 30038669

Cwikiel J, Seljeflot I, Berge E, Njerve IU, Ulsaker H, Arnesen H, Flaa A (2018)
Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease
Cytokine, 105, 17-22
DOI 10.1016/j.cyto.2018.02.006, PubMed 29433015

Dhillon AK, Kummen M, Trøseid M, Åkra S, Liaskou E, Moum B, Vesterhus M, Karlsen TH, Seljeflot I, Hov JR (2018)
Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
Liver Int, 39 (2), 371-381
DOI 10.1111/liv.13979, PubMed 30269440

Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
Clin Appl Thromb Hemost, 24 (7), 1088-1094
DOI 10.1177/1076029618764847, PubMed 29695176

Heier M, Espeland CN, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Fugelseth D, Dahl-Jørgensen K (2018)
Preserved endothelial function in young adults with type 1 diabetes
PLoS One, 13 (10), e0206523
DOI 10.1371/journal.pone.0206523, PubMed 30359432

Heier M, Stensæth KH, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K (2018)
Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study
Eur Heart J Cardiovasc Imaging, 19 (6), 694-700
DOI 10.1093/ehjci/jex178, PubMed 28950341

Hoel H, Hove-Skovsgaard M, Hov JR, Gaardbo JC, Holm K, Kummen M, Rudi K, Nwosu F, Valeur J, Gelpi M, Seljeflot I, Ueland PM, Gerstoft J, Ullum H, Aukrust P, Nielsen SD, Trøseid M (2018)
Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction
Sci Rep, 8 (1), 6725
DOI 10.1038/s41598-018-25168-3, PubMed 29712976

Horjen AW, Ulimoen SR, Norseth J, Svendsen JH, Smith P, Arnesen H, Seljeflot I, Tveit A (2018)
High-sensitivity troponin I in persistent atrial fibrillation - relation to NT-proBNP and markers of inflammation and haemostasis
Scand J Clin Lab Invest, 78 (5), 386-392
DOI 10.1080/00365513.2018.1481224, PubMed 29933716

Langseth MS, Opstad TB, Bratseth V, Solheim S, Arnesen H, Pettersen AÅ, Seljeflot I, Helseth R (2018)
Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease
Eur J Prev Cardiol, 25 (7), 762-769
DOI 10.1177/2047487318760618, PubMed 29473463

Mayerhofer CCK, Awoyemi AO, Moscavitch SD, Lappegård KT, Hov JR, Aukrust P, Hovland A, Lorenzo A, Halvorsen S, Seljeflot I, Gullestad L, Trøseid M, Broch K (2018)
Design of the GutHeart-targeting gut microbiota to treat heart failure-trial: a Phase II, randomized clinical trial
ESC Heart Fail, 5 (5), 977-984
DOI 10.1002/ehf2.12332, PubMed 30088346

Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, Husebye T, Aukrust P, Yndestad A, Andersen GØ, Barratt-Due A, Mollnes TE (2018)
Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
ESC Heart Fail, 5 (3), 292-301
DOI 10.1002/ehf2.12266, PubMed 29424484

Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
Int J Cardiol, 268, 187-192
DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279

Rocca B, Fox KAA, Ajjan RA, Andreotti F, Baigent C, Collet JP, Grove EL, Halvorsen S, Huber K, Morais J, Patrono C, Rubboli A, Seljeflot I, Sibbing D, Siegbahn A, Ten Berg J, Vilahur G, Verheugt FWA, Wallentin L, Weiss TW, Wojta J, Storey RF (2018)
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
Eur Heart J, 39 (19), 1672-1686f
DOI 10.1093/eurheartj/ehy066, PubMed 29509886

Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
J Am Coll Cardiol, 72 (2), 187-198
DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293

Åkra S, Aksnes TA, Flaa A, Eggesbø HB, Opstad TB, Njerve IU, Seljeflot I (2018)
Interleukin-18 and the NLR family pyrin domain containing-3 inflammasome in adipose tissue are strongly associated with glucometabolic variables in a cohort of middle-aged men
Diab Vasc Dis Res, 15 (5), 458-464
DOI 10.1177/1479164118785307, PubMed 29972041

Publications 2017

Bratseth V, Byrkjeland R, Njerve IU, Solheim S, Arnesen H, Seljeflot I (2017)
Procoagulant activity in patients with combined type 2 diabetes and coronary artery disease: No effects of long-term exercise training
Diab Vasc Dis Res, 14 (2), 144-151
DOI 10.1177/1479164116679080, PubMed 28111966

Byrkjeland R, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2017)
Reduced endothelial activation after exercise is associated with improved HbA_1c in patients with type 2 diabetes and coronary artery disease
Diab Vasc Dis Res, 14 (2), 94-103
DOI 10.1177/1479164116679077, PubMed 28111980

Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I (2017)
Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity
PLoS One, 12 (2), e0172558
DOI 10.1371/journal.pone.0172558, PubMed 28207887

Cwikiel J, Seljeflot I, Berge E, Arnesen H, Wachtell K, Ulsaker H, Flaa A (2017)
Pro-coagulant activity during exercise testing in patients with coronary artery disease
Thromb J, 15, 3
DOI 10.1186/s12959-016-0127-8, PubMed 28115916

Ellingsen DG, Seljeflot I, Thomassen Y, Thomassen M, Bakke B, Ulvestad B (2017)
Biomarkers of endothelial activation and thrombosis in tunnel construction workers exposed to airborne contaminants
Int Arch Occup Environ Health, 90 (4), 309-317
DOI 10.1007/s00420-017-1199-x, PubMed 28124139

Gharagozlian S, Hansen R, Haugen M, Johansen O, Seierstad SL, Seljeflot I, Arnesen H (2017)
Changes in dietary pattern when including 700 g of salmon per week to patients with atherosclerotic heart disease
Clin. Nutr. ESPEN, 19, 38-44
DOI 10.1016/j.clnesp.2017.02.004

Heier M, Borja MS, Brunborg C, Seljeflot I, Margeirsdottir HD, Hanssen KF, Dahl-Jørgensen K, Oda MN (2017)
Reduced HDL function in children and young adults with type 1 diabetes
Cardiovasc Diabetol, 16 (1), 85
DOI 10.1186/s12933-017-0570-2, PubMed 28683835

Horjen AW, Seljeflot I, Berge T, Smith P, Arnesen H, Tveit A (2017)
Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation
Thromb J, 15, 30
DOI 10.1186/s12959-017-0153-1, PubMed 29299030

Hove-Skovsgaard M, Gaardbo JC, Kolte L, Winding K, Seljeflot I, Svardal A, Berge RK, Gerstoft J, Ullum H, Trøseid M, Nielsen SD (2017)
HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation
BMC Infect Dis, 17 (1), 234
DOI 10.1186/s12879-017-2334-8, PubMed 28356058

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Norseth J, Arnesen H, Solheim S (2017)
Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study
JRSM Cardiovasc Dis, 6, 2048004017729984
DOI 10.1177/2048004017729984, PubMed 28932392

Njerve IU, Åkra S, Weiss TW, Solheim S, Øvstebø R, Aass HCD, Byrkjeland R, Arnesen H, Seljeflot I (2017)
A Double-Blinded Randomized Study Investigating a Possible Anti-Inflammatory Effect of Saxagliptin versus Placebo as Add-On Therapy in Patients with Both Type 2 Diabetes And Stable Coronary Artery Disease
Mediators Inflamm, 2017, 5380638
DOI 10.1155/2017/5380638, PubMed 28596642

Opstad TB, Seljeflot I, Bøhmer E, Arnesen H, Halvorsen S (2017)
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
Cardiology, 139 (1), 17-24
DOI 10.1159/000481684, PubMed 29141241

Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
Sci Rep, 7 (1), 11945
DOI 10.1038/s41598-017-12372-w, PubMed 28931920

Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
PLoS One, 12 (3), e0173034
DOI 10.1371/journal.pone.0173034, PubMed 28253327

Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I (2017)
vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease
Thromb J, 15, 28
DOI 10.1186/s12959-017-0151-3, PubMed 29200971

Wexels F, Dahl OE, Pripp AH, Seljeflot I (2017)
Thrombin Generation in Patients With Suspected Venous Thromboembolism
Clin Appl Thromb Hemost, 23 (5), 416-421
DOI 10.1177/1076029617700999, PubMed 28335612

Publications 2016

Bliksøen M, Mariero LH, Torp MK, Baysa A, Ytrehus K, Haugen F, Seljeflot I, Vaage J, Valen G, Stensløkken KO (2016)
Extracellular mtDNA activates NF-κB via toll-like receptor 9 and induces cell death in cardiomyocytes
Basic Res Cardiol, 111 (4), 42
DOI 10.1007/s00395-016-0553-6, PubMed 27164906

Byrkjeland R, Stensæth KH, Anderssen S, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2016)
Effects of exercise training on carotid intima-media thickness in patients with type 2 diabetes and coronary artery disease. Influence of carotid plaques
Cardiovasc Diabetol, 15, 13
DOI 10.1186/s12933-016-0336-2, PubMed 26801098

Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
Monocyte-derived circulating microparticles (CD14⁺, CD14⁺/CD11b⁺ and CD14⁺/CD142⁺) are related to long-term prognosis for cardiovascular mortality in STEMI patients
Int J Cardiol, 227, 876-881
DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085

Haissman JM, Haugaard AK, Knudsen A, Kristoffersen US, Seljeflot I, Pedersen KK, Lebech AM, Hasbak P, Kjær A, Ostrowski SR, Gerstoft J, Trøseid M, Nielsen SD (2016)
Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis
J Acquir Immune Defic Syndr, 73 (5), 507-513
DOI 10.1097/QAI.0000000000001148, PubMed 27509250

Helseth R, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2016)
The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris
Mediators Inflamm, 2016, 2182358
DOI 10.1155/2016/2182358, PubMed 28074081

Horjen AW, Ulimoen SR, Enger S, Norseth J, Seljeflot I, Arnesen H, Tveit A (2016)
Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing
BMC Cardiovasc Disord, 16, 79
DOI 10.1186/s12872-016-0255-x, PubMed 27142292

Laake K, Seljeflot I, Schmidt EB, Myhre P, Tveit A, Arnesen H, Solheim S (2016)
Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
J Lipids, 2016, 4945720
DOI 10.1155/2016/4945720, PubMed 26989512

Myhre PL, Laake K, Seljeflot I, Solheim S, Arnesen H (2016)
[Clinical research on elderly]
Tidsskr Nor Laegeforen, 136 (3), 208
DOI 10.4045/tidsskr.15.1300, PubMed 26860377

Neerland BE, Hall RJ, Seljeflot I, Frihagen F, MacLullich AM, Raeder J, Wyller TB, Watne LO (2016)
Associations Between Delirium and Preoperative Cerebrospinal Fluid C-Reactive Protein, Interleukin-6, and Interleukin-6 Receptor in Individuals with Acute Hip Fracture
J Am Geriatr Soc, 64 (7), 1456-63
DOI 10.1111/jgs.14238, PubMed 27341529

Njerve IU, Byrkjeland R, Arnesen H, Åkra S, Solheim S, Seljeflot I (2016)
Effects of long-term exercise training on adipose tissue expression of fractalkine and MCP-1 in patients with type 2 diabetes and stable coronary artery disease: a substudy of a randomized controlled trial
Diabetes Metab Syndr Obes, 9, 55-62
DOI 10.2147/DMSO.S96299, PubMed 27042130

Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
Combined Elevated Levels of the Proinflammatory Cytokines IL-18 and IL-12 Are Associated with Clinical Events in Patients with Coronary Artery Disease: An Observational Study
Metab Syndr Relat Disord, 14 (5), 242-8
DOI 10.1089/met.2015.0130, PubMed 27058587

Opstad TB, Brusletto BS, Arnesen H, Pettersen AÅ, Seljeflot I (2016)
Cigarette smoking represses expression of cytokine IL-12 and its regulator miR-21-An observational study in patients with coronary artery disease
Immunobiology, 222 (2), 169-175
DOI 10.1016/j.imbio.2016.10.007, PubMed 27765464

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
J Am Heart Assoc, 5 (6)
DOI 10.1161/JAHA.115.003014, PubMed 27412895

Wexels F, Seljeflot I, Pripp AH, Dahl OE (2016)
D-Dimer and prothrombin fragment 1 + 2 in urine and plasma in patients with clinically suspected venous thromboembolism
Blood Coagul Fibrinolysis, 27 (4), 396-400
DOI 10.1097/MBC.0000000000000461, PubMed 26595215

Publications 2015

Andric T, Weiss TW, Huber K, Arnesen H, Seljeflot I (2015)
Effects of diet and/or n-3 fatty acid supplementation on components of the interleukin-6 trans-signalling system in elderly men
Scand J Clin Lab Invest, 75 (8), 646-51
DOI 10.3109/00365513.2015.1063002, PubMed 26179891

Berg IJ, van der Heijde D, Dagfinrud H, Seljeflot I, Olsen IC, Kvien TK, Semb AG, Provan SA (2015)
Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study
J Rheumatol, 42 (4), 645-53
DOI 10.3899/jrheum.141018, PubMed 25641897

Byrkjeland R, Njerve IU, Anderssen S, Arnesen H, Seljeflot I, Solheim S (2015)
Effects of exercise training on HbA1c and VO2peak in patients with type 2 diabetes and coronary artery disease: A randomised clinical trial
Diab Vasc Dis Res, 12 (5), 325-33
DOI 10.1177/1479164115590552, PubMed 26092822

Ellingsen DG, Ulvestad B, Bakke B, Seljeflot I, Barregard L, Thomassen Y (2015)
Serum pneumoproteins in tunnel construction workers
Int Arch Occup Environ Health, 88 (7), 943-51
DOI 10.1007/s00420-015-1023-4, PubMed 25632885

Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
Thromb J, 13, 31
DOI 10.1186/s12959-015-0061-1, PubMed 26396552

Heier M, Margeirsdottir HD, Gaarder M, Stensæth KH, Brunborg C, Torjesen PA, Seljeflot I, Hanssen KF, Dahl-Jørgensen K (2015)
Soluble RAGE and atherosclerosis in youth with type 1 diabetes: a 5-year follow-up study
Cardiovasc Diabetol, 14, 126
DOI 10.1186/s12933-015-0292-2, PubMed 26408307

Heier M, Margeirsdottir HD, Torjesen PA, Seljeflot I, Stensæth KH, Gaarder M, Brunborg C, Hanssen KF, Dahl-Jørgensen K (2015)
The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes
Diab Vasc Dis Res, 12 (2), 139-45
DOI 10.1177/1479164114560910, PubMed 25616705

Helseth R, Opstad T, Solheim S, Lunde K, Arnesen H, Seljeflot I (2015)
The Effect of Intracoronary Stem Cell Injection on Markers of Leukocyte Activation in Acute Myocardial Infarction
Cardiol Res, 6 (1), 209-215
DOI 10.14740/cr375w, PubMed 28197227

Horjen AW, Ulimoen SR, Seljeflot I, Smith P, Arnesen H, Norseth J, Tveit A (2015)
High-Sensitivity Troponin I and Rhythm Outcome after Electrical Cardioversion for Persistent Atrial Fibrillation
Cardiology, 133 (4), 233-8
DOI 10.1159/000442249, PubMed 26697854

Lindholm EE, Aune E, Seljeflot I, Otterstad JE, Kirkebøen KA (2015)
Biomarkers of inflammation in major vascular surgery: a prospective randomised trial
Acta Anaesthesiol Scand, 59 (6), 773-87
DOI 10.1111/aas.12466, PubMed 25626738

Laake K, Seljeflot I, Fagerland MW, Njerve IU, Arnesen H, Solheim S (2015)
Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome
Mediators Inflamm, 2015, 373070
DOI 10.1155/2015/373070, PubMed 25733777

Pettersen AA, Arnesen H, Seljeflot I (2015)
A brief review on high on-aspirin residual platelet reactivity
Vascul Pharmacol, 67-69, 6-9
DOI 10.1016/j.vph.2015.03.018, PubMed 25869498

Skrede K, Wyller TB, Watne LO, Seljeflot I, Juliebø V (2015)
Is there a role for monocyte chemoattractant protein-1 in delirium? Novel observations in elderly hip fracture patients
BMC Res Notes, 8, 186
DOI 10.1186/s13104-015-1129-5, PubMed 25943983

Trøseid M, Nestvold TK, Nielsen EW, Thoresen H, Seljeflot I, Lappegård KT (2015)
Soluble CD14 is associated with markers of vascular dysfunction in bariatric surgery patients
Metab Syndr Relat Disord, 13 (3), 119-24
DOI 10.1089/met.2014.0111, PubMed 25562385

Publications 2014

Byrkjeland R, Edvardsen E, Njerve IU, Arnesen H, Seljeflot I, Solheim S (2014)
Insulin levels and HOMA index are associated with exercise capacity in patients with type 2 diabetes and coronary artery disease
Diabetol Metab Syndr, 6 (1), 36
DOI 10.1186/1758-5996-6-36, PubMed 24612649

Furenes EB, Opstad TB, Solheim S, Lunde K, Arnesen H, Seljeflot I (2014)
The influence of autologous bone marrow stem cell transplantation on matrix metalloproteinases in patients treated for acute ST-elevation myocardial infarction
Mediators Inflamm, 2014, 385901
DOI 10.1155/2014/385901, PubMed 25294955

Heier M, Margeirsdottir HD, Brunborg C, Hanssen KF, Dahl-Jørgensen K, Seljeflot I (2014)
Inflammation in childhood type 1 diabetes; influence of glycemic control
Atherosclerosis, 238 (1), 33-7
DOI 10.1016/j.atherosclerosis.2014.11.018, PubMed 25437887

Helseth R, Seljeflot I, Opstad T, Solheim S, Freynhofer M, Arnesen H, Huber K, Weiss T (2014)
Genes expressed in coronary thrombi are associated with ischemic time in patients with acute myocardial infarction
Thromb Res, 135 (2), 329-33
DOI 10.1016/j.thromres.2014.11.028, PubMed 25496999

Helseth R, Solheim S, Opstad T, Hoffmann P, Arnesen H, Seljeflot I (2014)
The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention
Mediators Inflamm, 2014, 608414
DOI 10.1155/2014/608414, PubMed 24737925

Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
PLoS One, 9 (11), e112359
DOI 10.1371/journal.pone.0112359, PubMed 25390695

Laake K, Myhre P, Nordby LM, Seljeflot I, Abdelnoor M, Smith P, Tveit A, Arnesen H, Solheim S (2014)
Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study
BMC Geriatr, 14, 74
DOI 10.1186/1471-2318-14-74, PubMed 24928284

Njerve IU, Solheim S, Lunde K, Hoffmann P, Arnesen H, Seljeflot I (2014)
Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
Cytokine, 69 (1), 131-5
DOI 10.1016/j.cyto.2014.05.022, PubMed 24930044

Opstad TB, Arnesen H, Pettersen AÅ, Seljeflot I (2014)
The MMP-9 -1562 C/T polymorphism in the presence of metabolic syndrome increases the risk of clinical events in patients with coronary artery disease
PLoS One, 9 (9), e106816
DOI 10.1371/journal.pone.0106816, PubMed 25191702

Pedersen KK, Manner IW, Seljeflot I, Kvale D, Os I, Gerstoft J, Nielsen SD, Trøseid M (2014)
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
J Acquir Immune Defic Syndr, 67 (4), 370-4
DOI 10.1097/QAI.0000000000000339, PubMed 25226210

Sveen KA, Dahl-Jørgensen K, Stensaeth KH, Angel K, Seljeflot I, Sell DR, Monnier VM, Hanssen KF (2014)
Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
J Diabetes Complications, 29 (3), 407-12
DOI 10.1016/j.jdiacomp.2014.12.011, PubMed 25600701

Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
Blood Press, 24 (1), 48-54
DOI 10.3109/08037051.2014.976979, PubMed 25483553

Wexels F, Dahl OE, Pripp AH, Seljeflot I, Borris LC, Haslund A, Gudmundsen TE, Lauritzen T, Lassen MR (2014)
Prothrombin fragment 1+2 in urine as a marker on coagulation activity in patients with suspected pulmonary embolism
Thromb Res, 134 (1), 68-71
DOI 10.1016/j.thromres.2014.04.011, PubMed 24824294

Wonnerth A, Katsaros KM, Krychtiuk KA, Speidl WS, Kaun C, Thaler K, Huber K, Wojta J, Maurer G, Seljeflot I, Arnesen H, Weiss TW (2014)
Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
Metabolism, 63 (5), 647-53
DOI 10.1016/j.metabol.2014.02.005, PubMed 24629561

Publications 2013

Arnesen H, Seljeflot I (2013)
The challenge of judging data on the effects of N-3 fatty acids in CHD
Scand Cardiovasc J, 47 (2), 67-8
DOI 10.3109/14017431.2012.761348, PubMed 23327650

Berge T, Ulimoen SR, Enger S, Arnesen H, Seljeflot I, Tveit A (2013)
Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly
Scand J Clin Lab Invest, 73 (4), 326-33
DOI 10.3109/00365513.2013.780093, PubMed 23586783

Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
Eur J Heart Fail, 15 (5), 565-72
DOI 10.1093/eurjhf/hfs215, PubMed 23288914

Lindholm EE, Aune E, Norén CB, Seljeflot I, Hayes T, Otterstad JE, Kirkeboen KA (2013)
The anesthesia in abdominal aortic surgery (ABSENT) study: a prospective, randomized, controlled trial comparing troponin T release with fentanyl-sevoflurane and propofol-remifentanil anesthesia in major vascular surgery
Anesthesiology, 119 (4), 802-12
DOI 10.1097/ALN.0b013e31829bd883, PubMed 23838709

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2013)
The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients
PLoS One, 8 (9), e74498
DOI 10.1371/journal.pone.0074498, PubMed 24040261

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
IL-6 signalling in patients with acute ST-elevation myocardial infarction
Results Immunol, 4, 8-13
DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455

Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
Frailty indicators and functional status in older patients after colorectal cancer surgery
J Geriatr Oncol, 5 (1), 26-32
DOI 10.1016/j.jgo.2013.08.001, PubMed 24484715

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
Thromb J, 11 (1), 1
DOI 10.1186/1477-9560-11-1, PubMed 23311309

Tveit A, Seljeflot I, Smith P, Arnesen H, Svendsen JH (2013)
Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
Immunobiology, 218 (10), 1256-60
DOI 10.1016/j.imbio.2013.04.014, PubMed 23731775

Weiss TW, Arnesen H, Seljeflot I (2013)
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness
Metabolism, 62 (7), 1008-13
DOI 10.1016/j.metabol.2013.01.019, PubMed 23428306

Wexels F, Haslund A, Dahl OE, Pripp AH, Gudmundsen TE, Laszlo F, Seljeflot I, Borris LC, Lassen MR (2013)
Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification
Thromb Res, 131 (6), 560-3
DOI 10.1016/j.thromres.2013.04.019, PubMed 23680105

Publications 2012

Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D (2012)
The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness
Atherosclerosis, 225 (1), 160-5
DOI 10.1016/j.atherosclerosis.2012.08.033, PubMed 23014354

Bliksøen M, Mariero LH, Ohm IK, Haugen F, Yndestad A, Solheim S, Seljeflot I, Ranheim T, Andersen GØ, Aukrust P, Valen G, Vinge LE (2012)
Increased circulating mitochondrial DNA after myocardial infarction
Int J Cardiol, 158 (1), 132-4
DOI 10.1016/j.ijcard.2012.04.047, PubMed 22578950

Bratseth V, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment
Thromb J, 10 (1), 12
DOI 10.1186/1477-9560-10-12, PubMed 22883224

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
The effects of long-term oral benfotiamine supplementation on peripheral nerve function and inflammatory markers in patients with type 1 diabetes: a 24-month, double-blind, randomized, placebo-controlled trial
Diabetes Care, 35 (5), 1095-7
DOI 10.2337/dc11-1895, PubMed 22446172

Fraser DA, Diep LM, Hovden IA, Nilsen KB, Sveen KA, Seljeflot I, Hanssen KF (2012)
Response to Comment on: Fraser et al. The Effects of Long-Term Oral Benfotiamine Supplementation on Peripheral Nerve Function and Inflammatory Markers in Patients With Type 1 Diabetes: A 24-Month, Double-Blind, Randomized, Placebo-Controlled Trial. Diabetes Care 2012;35:1095-1097
Diabetes Care, 35 (11), E80
DOI 10.2337/dc12-1124

Halvorsen S, Seljeflot I, Weiss T, Bøhmer E, Arnesen H (2012)
Inflammatory and thrombotic markers in patients with ST-elevation myocardial infarction treated with thrombolysis and early PCI: a NORDISTEMI substudy
Thromb Res, 130 (3), 495-500
DOI 10.1016/j.thromres.2012.04.016, PubMed 22607887

Hassellund SS, Flaa A, Kjeldsen SE, Seljeflot I, Karlsen A, Erlund I, Rostrup M (2012)
Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: a double-blind randomized placebo-controlled crossover study
J Hum Hypertens, 27 (2), 100-6
DOI 10.1038/jhh.2012.4, PubMed 22336903

Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
J Hum Hypertens, 27 (2), 126-30
DOI 10.1038/jhh.2011.116, PubMed 22258209

Lindholm E, Seljeflot I, Aune E, Kirkebøen KA (2012)
Proinflammatory cytokines and complement activation in salvaged blood from abdominal aortic aneurism surgery and total hip replacement surgery
Transfusion, 52 (8), 1761-9
DOI 10.1111/j.1537-2995.2011.03528.x, PubMed 22304534

Njerve IU, Pettersen AÅ, Opstad TB, Arnesen H, Seljeflot I (2012)
Fractalkine and its receptor (CX3CR1) in patients with stable coronary artery disease and diabetes mellitus
Metab Syndr Relat Disord, 10 (6), 400-6
DOI 10.1089/met.2012.0052, PubMed 22897138

Pettersen AÅ, Arnesen H, Opstad TB, Bratseth V, Seljeflot I (2012)
Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease
Thromb Res, 130 (3), 424-8
DOI 10.1016/j.thromres.2012.06.016, PubMed 22795340

Pettersen AÅ, Seljeflot I, Abdelnoor M, Arnesen H (2012)
High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)
J Am Heart Assoc, 1 (3), e000703
DOI 10.1161/JAHA.112.000703, PubMed 23130135

Seljeflot I (2012)
Plasma asymmetric dimethylarginine in patients with acute decompensation of chronic heart failure
Heart, 98 (11), 831-2
DOI 10.1136/heartjnl-2012-301932, PubMed 22581731

Seljeflot I, R Ulimoen S, Enger S, Bratseth V, Arnesen H, Tveit A (2012)
Asymmetric Dimethylarginine Levels are Highly Associated With Atrial Fibrillation in an Elderly Population
Cardiol Res, 3 (3), 109-115
DOI 10.4021/cr175w, PubMed 28352406

Publications 2011

Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
Heart, 97 (6), 460-5
DOI 10.1136/hrt.2010.206714, PubMed 21270073

Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
Diabetes, 60 (5), 1544-51
DOI 10.2337/db10-1493, PubMed 21464440

Byrkjeland R, Nilsson BB, Westheim AS, Arnesen H, Seljeflot I (2011)
Inflammatory markers as related to disease severity in patients with chronic heart failure: limited effects of exercise training
Scand J Clin Lab Invest, 71 (7), 598-605
DOI 10.3109/00365513.2011.598943, PubMed 21831004

Grøgaard HK, Solheim S, Landsverk KS, Seljeflot I, Hoffmann P, Arnesen H, Ilebekk A (2011)
Circulating CD34⁺ progenitor cells and growth factors in patients treated with PCI for acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 71 (4), 322-9
DOI 10.3109/00365513.2011.565367, PubMed 21463159

Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
Br J Nutr, 106 (4), 557-71
DOI 10.1017/S0007114511000353, PubMed 21806852

Kirkhus B, Lamglait A, Eilertsen KE, Falch E, Haider T, Vik H, Hoem N, Hagve TA, Basu S, Olsen E, Seljeflot I, Nyberg L, Elind E, Ulven SM (2011)
Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects
Br J Nutr, 107 (9), 1339-49
DOI 10.1017/S0007114511004508, PubMed 21917191

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
BMC Endocr Disord, 11, 14
DOI 10.1186/1472-6823-11-14, PubMed 21801387

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
J Thromb Haemost, 9 (8), 1468-74
DOI 10.1111/j.1538-7836.2011.04377.x, PubMed 21624046

Mistry N, Abdelnoor M, Seljeflot I, Hoffmann P, Bøhmer E, Bjørnerheim R, Kjeldsen SE, Halvorsen S (2011)
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase
J Card Fail, 17 (6), 479-86
DOI 10.1016/j.cardfail.2011.02.006, PubMed 21624736

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2011)
Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study
Cardiovasc Diabetol, 10, 110
DOI 10.1186/1475-2840-10-110, PubMed 22141572

Opstad TB, Pettersen AA, Weiss TW, Akra S, Øvstebø R, Arnesen H, Seljeflot I (2011)
Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease
Clin Chim Acta, 413 (1-2), 113-20
DOI 10.1016/j.cca.2011.09.004, PubMed 21963461

Pettersen AA, Arnesen H, Opstad TB, Seljeflot I (2011)
The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
Thromb J, 9, 4
DOI 10.1186/1477-9560-9-4, PubMed 21426546

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2011)
The influence of intracoronary injection of bone marrow cells on prothrombotic markers in patients with acute myocardial infarction
Thromb Res, 130 (5), 765-8
DOI 10.1016/j.thromres.2011.11.045, PubMed 22192151

Weiss TW, Arnesen H, Trøseid M, Kaun C, Hjerkinn EM, Huber K, Wojta J, Seljeflot I (2011)
Adipose tissue expression of interleukin-18 mRNA is elevated in subjects with metabolic syndrome and independently associated with fasting glucose
Wien Klin Wochenschr, 123 (21-22), 650-4
DOI 10.1007/s00508-011-0028-6, PubMed 21842238

Weiss TW, Seljeflot I, Hjerkinn EM, Arnesen H (2011)
Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease
Int J Clin Pract, 65 (9), 939-44
DOI 10.1111/j.1742-1241.2011.02717.x, PubMed 21849008

Publications 2010

Arnesen H, Seljeflot I (2010)
Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation
Cell Mol Biol (Noisy-le-grand), 56 (1), 18-27
DOI 10.1170/T875, PubMed 20196966

Bøhmer E, Seljeflot I, Arnesen H, Hoffmann P, Abdelnoor M, Halvorsen S (2010)
The association between metabolic syndrome and infarct size in patients with acute myocardial infarction
Scand J Clin Lab Invest, 70 (4), 287-93
DOI 10.3109/00365513.2010.481819, PubMed 20429699

Bøhn SK, Myhrstad MC, Thoresen M, Holden M, Karlsen A, Tunheim SH, Erlund I, Svendsen M, Seljeflot I, Moskaug JO, Duttaroy AK, Laake P, Arnesen H, Tonstad S, Collins A, Drevon CA, Blomhoff R (2010)
Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers
BMC Med, 8, 54
DOI 10.1186/1741-7015-8-54, PubMed 20846424

Grøgaard HK, Seljeflot I, Lunde K, Solheim S, Aakhus S, Forfang K, Arnesen H, Ilebekk A (2010)
Cell treatment after acute myocardial infarction prevents early decline in circulating IGF-1
Scand Cardiovasc J, 44 (5), 267-72
DOI 10.3109/14017431.2010.490949, PubMed 21080844

Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2010)
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
Cardiovasc Diabetol, 9, 47
DOI 10.1186/1475-2840-9-47, PubMed 20809989

Kringen MK, Haug KB, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brørs O (2010)
Genetic variation of VKORC1 and CYP4F2 genes related to warfarin maintenance dose in patients with myocardial infarction
J Biomed Biotechnol, 2011, 739751
DOI 10.1155/2011/739751, PubMed 21127708

Kringen MK, Narum S, Lygren I, Seljeflot I, Sandset PM, Trøseid AM, Johansen PW, Brørs O, Holthe MR (2010)
Reduced platelet function and role of drugs in acute gastrointestinal bleeding
Basic Clin Pharmacol Toxicol, 108 (3), 194-201
DOI 10.1111/j.1742-7843.2010.00643.x, PubMed 21118353

Nilsson BB, Westheim A, Risberg MA, Arnesen H, Seljeflot I (2010)
No effect of group-based aerobic interval training on N-terminal pro- B-type natriuretic peptide levels in patients with chronic heart failure
Scand Cardiovasc J, 44 (4), 223-9
DOI 10.3109/14017431.2010.496869, PubMed 20636229

Opstad TB, Pettersen AA, Bratseth V, Arnesen H, Seljeflot I (2010)
The influence of tissue factor and tissue factor pathway inhibitor polymorphisms on thrombin generation in stable coronary artery disease
Pathophysiol Haemost Thromb, 37 (2-4), 98-103
DOI 10.1159/000327491, PubMed 21555871

Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I (2010)
Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes
Thromb J, 8, 7
DOI 10.1186/1477-9560-8-7, PubMed 20444258

Rønning B, Wyller TB, Seljeflot I, Jordhøy MS, Skovlund E, Nesbakken A, Kristjansson SR (2010)
Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients
Age Ageing, 39 (6), 758-61
DOI 10.1093/ageing/afq123, PubMed 20843962

Seljeflot I, Nilsson BB, Westheim AS, Bratseth V, Arnesen H (2010)
The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training
J Card Fail, 17 (2), 135-42
DOI 10.1016/j.cardfail.2010.09.003, PubMed 21300303

Solheim S, Seljeflot I, Lunde K, Bjørnerheim R, Aakhus S, Forfang K, Arnesen H (2010)
Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy
Am J Cardiol, 106 (9), 1197-200
DOI 10.1016/j.amjcard.2010.06.043, PubMed 21029812

Trøseid M, Seljeflot I, Arnesen H (2010)
The role of interleukin-18 in the metabolic syndrome
Cardiovasc Diabetol, 9, 11
DOI 10.1186/1475-2840-9-11, PubMed 20331890

Tveit A, Arnesen H, Smith P, Bratseth V, Seljeflot I (2010)
L-arginine, asymmetric dimethylarginine and rhythm outcome after electrical cardioversion for atrial fibrillation
Cardiology, 117 (3), 176-80
DOI 10.1159/000321402, PubMed 21063118

Weiss TW, Furenes EB, Trøseid M, Solheim S, Hjerkinn EM, Seljeflot I, Arnesen H (2010)
Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men
Thromb Haemost, 103 (3), 679-81
DOI 10.1160/TH09-05-0317, PubMed 20076844

Publications 2009

Bangstad HJ, Seljeflot I, Berg TJ, Hanssen KF (2009)
Renal tubulointerstitial expansion is associated with endothelial dysfunction and inflammation in type 1 diabetes
Scand J Clin Lab Invest, 69 (1), 138-44
DOI 10.1080/00365510802444080, PubMed 18846477

Bøhmer E, Hoffmann P, Abdelnoor M, Seljeflot I, Halvorsen S (2009)
Troponin T concentration 3 days after acute ST-elevation myocardial infarction predicts infarct size and cardiac function at 3 months
Cardiology, 113 (3), 207-12
DOI 10.1159/000201991, PubMed 19218804

Furenes EB, Arnesen H, Solheim S, Grøgaard HK, Hoffmann P, Seljeflot I (2009)
The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
Thromb Res, 124 (5), 560-4
DOI 10.1016/j.thromres.2009.04.001, PubMed 19410278

Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
Cardiovasc Diabetol, 8, 6
DOI 10.1186/1475-2840-8-6, PubMed 19183453

Taraldsrud E, Grøgaard HK, Solheim S, Lunde K, Fløisand Y, Arnesen H, Seljeflot I, Egeland T (2009)
Age and stress related phenotypical changes in bone marrow CD34+ cells
Scand J Clin Lab Invest, 69 (1), 79-84
DOI 10.1080/00365510802419447, PubMed 18836945

Trøseid M, Arnesen H, Hjerkinn EM, Seljeflot I (2009)
Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men
Metabolism, 58 (11), 1543-9
DOI 10.1016/j.metabol.2009.04.031, PubMed 19595382

Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2009)
The effect of exercise on serum levels of interleukin-18 and components of the metabolic syndrome
Metab Syndr Relat Disord, 7 (6), 579-84
DOI 10.1089/met.2009.0003, PubMed 19900154

Trøseid M, Seljeflot I, Weiss TW, Klemsdal TO, Hjerkinn EM, Arnesen H (2009)
Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome
Atherosclerosis, 209 (2), 337-9
DOI 10.1016/j.atherosclerosis.2009.09.028, PubMed 19836750

Tveit A, Bollmann A, Seljeflot I, Husser D, Stridh M, Sörnmo L, Arnesen H, Olsson SB, Smith P (2009)
Relation between atrial fibrillatory rate and markers of inflammation and haemostasis in persistent human atrial fibrillation
Thromb Haemost, 101 (3), 601-3
DOI 10.1160/TH08-07-0482, PubMed 19277431

Wennersberg MH, Smedman A, Turpeinen AM, Retterstøl K, Tengblad S, Lipre E, Aro A, Mutanen P, Seljeflot I, Basu S, Pedersen JI, Mutanen M, Vessby B (2009)
Dairy products and metabolic effects in overweight men and women: results from a 6-mo intervention study
Am J Clin Nutr, 90 (4), 960-8
DOI 10.3945/ajcn.2009.27664, PubMed 19710195

Publications 2008

Brodin E, Seljeflot I, Arnesen H, Hurlen M, Appelbom H, Hansen JB (2008)
Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment
Thromb Res, 123 (4), 573-9
DOI 10.1016/j.thromres.2008.03.018, PubMed 18474393

Ellingsen I, Seljeflot I, Arnesen H, Tonstad S (2008)
Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study
Nutr Metab Cardiovasc Dis, 19 (1), 8-14
DOI 10.1016/j.numecd.2008.01.006, PubMed 18472409

Furenes EB, Seljeflot I, Solheim S, Hjerkinn EM, Arnesen H (2008)
Long-term influence of diet and/or omega-3 fatty acids on matrix metalloproteinase-9 and pregnancy-associated plasma protein-A in men at high risk of coronary heart disease
Scand J Clin Lab Invest, 68 (3), 177-84
DOI 10.1080/00365510701663350, PubMed 17934973

Grundvold I, Tveit A, Smith P, Seljeflot I, Abdelnoor M, Arnesen H (2008)
The predictive value of transthoracic echocardiographic variables for sinus rhythm maintenance after electrical cardioversion of atrial fibrillation. Results from the CAPRAF study, a prospective, randomized, placebo-controlled study
Cardiology, 111 (1), 30-5
DOI 10.1159/000113424, PubMed 18239389

Haug KBF, Sharikabad MN, Kringen MK, Narum S, Sjaatil ST, Johansen PW, Kierulf P, Seljeflot I, Arnesen H, Brørs O (2008)
Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
Thromb J, 6, 7
DOI 10.1186/1477-9560-6-7, PubMed 18559094

Solheim S, Grøgaard HK, Hoffmann P, Arnesen H, Seljeflot I (2008)
Inflammatory responses after percutaneous coronary intervention in patients with acute myocardial infarction or stable angina pectoris
Scand J Clin Lab Invest, 68 (7), 555-62
DOI 10.1080/00365510701884584, PubMed 19378426

Solheim S, Seljeflot I, Lunde K, Aukrust P, Yndestad A, Grøgaard HK, Aakhus S, Forfang K, Arnesen H (2008)
Inflammatory responses after intracoronary injection of autologous mononuclear bone marrow cells in patients with acute myocardial infarction
Am Heart J, 155 (1), 55.e1-9
DOI 10.1016/j.ahj.2007.10.005, PubMed 18082489

Trøseid M, Seljeflot I, Hjerkinn EM, Arnesen H (2008)
Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia
Diabetes Care, 32 (3), 486-92
DOI 10.2337/dc08-1710, PubMed 19092166

Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H, Smith P (2008)
Angiotensin receptor blockers in the prevention of atrial fibrillation recurrence: Need for a definitive trial
Int. J. Cardiol., 127 (2), 278-279
DOI 10.1016/j.ijcard.2007.07.044

Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Arnesen H, Smith P (2008)
Candesartan, NT-proBNP and recurrence of atrial fibrillation after electrical cardioversion
Int J Cardiol, 131 (2), 234-9
DOI 10.1016/j.ijcard.2007.10.028, PubMed 18201783

Publications 2007

Aksnes TA, Seljeflot I, Torjesen PA, Höieggen A, Moan A, Kjeldsen SE (2007)
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity
Metabolism, 56 (11), 1470-7
DOI 10.1016/j.metabol.2007.06.012, PubMed 17950096

Eid HM, Reims H, Arnesen H, Kjeldsen SE, Lyberg T, Seljeflot I (2007)
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia
Metabolism, 56 (4), 464-9
DOI 10.1016/j.metabol.2006.11.003, PubMed 17379002

Ellingsen I, Hjerkinn EM, Seljeflot I, Arnesen H, Tonstad S (2007)
Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men
Br J Nutr, 99 (3), 674-81
DOI 10.1017/S0007114507832521, PubMed 17894919

Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO (2007)
Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives
Scand Cardiovasc J, 41 (5), 313-20
DOI 10.1080/14017430701411234, PubMed 17852781

Jonsson G, Abdelnoor M, Seljeflot I, Arnesen H, Hostmark AT, Kjeldsen SE, Os I, Westheim AS (2007)
The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients
J Cardiovasc Pharmacol, 49 (1), 27-32
DOI 10.1097/FJC.0b013e31802bdd8c, PubMed 17261960

Khoury J, Henriksen T, Seljeflot I, Mørkrid L, Frøslie KF, Tonstad S (2007)
Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study
BJOG, 114 (3), 279-88
DOI 10.1111/j.1471-0528.2006.01187.x, PubMed 17217362

Nylaende M, Kroese AJ, Morken B, Stranden E, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2007)
Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study
Vasc Med, 12 (4), 275-83
DOI 10.1177/1358863X07082720, PubMed 18048463

Tonstad S, Thorsrud H, Torjesen PA, Seljeflot I (2007)
Do novel risk factors differ between men and women aged 18 to 39 years with a high risk of coronary heart disease?
Metabolism, 56 (2), 260-6
DOI 10.1016/j.metabol.2006.10.006, PubMed 17224342

Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H (2007)
Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
Am J Cardiol, 99 (11), 1544-8
DOI 10.1016/j.amjcard.2007.01.030, PubMed 17531578

Tveit A, Seljeflot I, Grundvold I, Abdelnoor M, Smith P, Arnesen H (2007)
Levels of PAI-1 and outcome after electrical cardioversion for atrial fibrillation
Thromb Res, 121 (4), 447-53
DOI 10.1016/j.thromres.2007.06.014, PubMed 17698170

Publications 2006

Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
Thromb Res, 120 (1), 21-7
DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186

Bethune C, Seierstad SL, Seljeflot I, Johansen O, Arnesen H, Meltzer HM, Rosenlund G, Frøyland L, Lundebye AK (2006)
Dietary intake of differently fed salmon: a preliminary study on contaminants
Eur J Clin Invest, 36 (3), 193-201
DOI 10.1111/j.1365-2362.2006.01612.x, PubMed 16506965

Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Ellingsen I, Seljeflot I (2006)
Effect of diet and omega-3 fatty acid intervention on asymmetric dimethylarginine
Nutr Metab (Lond), 3, 4
DOI 10.1186/1743-7075-3-4, PubMed 16396682

Eid HM, Lyberg T, Arnesen H, Seljeflot I (2006)
Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH
Atherosclerosis, 194 (2), e1-8
DOI 10.1016/j.atherosclerosis.2006.11.008, PubMed 17141242

Ellingsen I, Hjerkinn EM, Arnesen H, Seljeflot I, Hjermann I, Tonstad S (2006)
Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study
Eur J Clin Nutr, 60 (3), 378-85
DOI 10.1038/sj.ejcn.1602327, PubMed 16306931

Hjerkinn EM, Abdelnoor M, Breivik L, Bergengen L, Ellingsen I, Seljeflot I, Aase O, Ole Klemsdal T, Hjermann I, Arnesen H (2006)
Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia
Eur J Cardiovasc Prev Rehabil, 13 (3), 325-33
DOI 10.1097/01.hjr.0000209817.28444.fb, PubMed 16926660

Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, Jørgensen JJ, Lindahl AK, Arnesen H, Seljeflot I, Kroese AJ (2006)
The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication
Eur J Vasc Endovasc Surg, 33 (1), 3-12
DOI 10.1016/j.ejvs.2006.08.007, PubMed 17055756

Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2006)
Prothrombotic activity is associated with the anatomical as well as the functional severity of peripheral arterial occlusive disease
Thromb Haemost, 95 (4), 702-7
DOI 10.1160/TH06-01-0007, PubMed 16601842

Nylaende M, Kroese A, Stranden E, Morken B, Sandbaek G, Lindahl AK, Arnesen H, Seljeflot I (2006)
Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease
Vasc Med, 11 (1), 21-8
DOI 10.1191/1358863x06vm662oa, PubMed 16669409

Schumacher A, Peersen K, Sommervoll L, Seljeflot I, Arnesen H, Otterstad JE (2006)
Physical performance is associated with markers of vascular inflammation in patients with coronary heart disease
Eur J Cardiovasc Prev Rehabil, 13 (3), 356-62
DOI 10.1097/01.hjr.0000188244.54287.96, PubMed 16926664

Seljeflot I, Larsen JR, Dahl-Jørgensen K, Hanssen KF, Arnesen H (2006)
Fibrinolytic activity is highly influenced by long-term glycemic control in Type 1 diabetic patients
J Thromb Haemost, 4 (3), 686-8
DOI 10.1111/j.1538-7836.2006.01803.x, PubMed 16460457

Solheim S, Pettersen AA, Arnesen H, Seljeflot I (2006)
No difference in the effects of clopidogrel and aspirin on inflammatory markers in patients with coronary heart disease
Thromb Haemost, 96 (5), 660-4
DOI 10.1160/TH06-06-0337, PubMed 17080224

Trøseid M, Hjerkinn EM, Seljeflot I, Klemsdal TO, Bergengen L, Breivik L, Arnesen H (2006)
Comparison of biochemical, functional and structural aspects of arterial wall properties in elderly men
Scand J Clin Lab Invest, 66 (2), 137-45
DOI 10.1080/00365510500474462, PubMed 16537247

Tveit A, Grundvold I, Olufsen M, Seljeflot I, Abdelnoor M, Arnesen H, Smith P (2006)
Candesartan in the prevention of relapsing atrial fibrillation
Int J Cardiol, 120 (1), 85-91
DOI 10.1016/j.ijcard.2006.08.086, PubMed 17113170

Aas AM, Seljeflot I, Torjesen PA, Diep LM, Thorsby PM, Birkeland KI (2006)
Blood glucose lowering by means of lifestyle intervention has different effects on adipokines as compared with insulin treatment in subjects with type 2 diabetes
Diabetologia, 49 (5), 872-80
DOI 10.1007/s00125-006-0205-8, PubMed 16555056

Publications 2005

Hjerkinn EM, Seljeflot I, Ellingsen I, Berstad P, Hjermann I, Sandvik L, Arnesen H (2005)
Influence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia
Am J Clin Nutr, 81 (3), 583-9
DOI 10.1093/ajcn/81.3.583, PubMed 15755826

Hjerkinn EM, Seljeflot I, Sandvik L, Hjermann I, Arnesen H (2005)
Markers of endothelial cell activation in elderly men at high risk for coronary heart disease
Scand J Clin Lab Invest, 65 (3), 201-9
DOI 10.1080/00365510510013613, PubMed 16095049

Hurlen M, Eikvar L, Seljeflot I, Arnesen H (2005)
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis
Thromb Res, 118 (4), 433-8
DOI 10.1016/j.thromres.2005.07.023, PubMed 16139331

Lindman AS, Pedersen JI, Arnesen H, Hjerkinn EM, Seljeflot I (2005)
Association between the factor VII haplotype containing the -402A allele and myocardial infarction in a population of elderly men at high risk for coronary heart disease
Thromb Haemost, 94 (1), 226-7
PubMed 16116695

Lindman AS, Pedersen JI, Hjerkinn EM, Veierød MB, Kavlie A, Arnesen H, Seljeflot I (2005)
The influence of the -401G/T and -402G/A polymorphisms of the coagulation FVII promoter on plasma levels of FVII
Thromb Res, 116 (4), 313-20
DOI 10.1016/j.thromres.2004.08.031, PubMed 16038716

Pedersen JI, Muller H, Seljeflot I, Kirkhus B (2005)
Palm oil versus hydrogenated soybean oil: effects on serum lipids and plasma haemostatic variables
Asia Pac J Clin Nutr, 14 (4), 348-57
PubMed 16326641

Schumacher A, Seljeflot I, Lerkerød AB, Sommervoll L, Otterstad JE, Arnesen H (2005)
Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease
Eur J Clin Invest, 35 (7), 431-7
DOI 10.1111/j.1365-2362.2005.01511.x, PubMed 16008544

Seierstad SL, Seljeflot I, Johansen O, Hansen R, Haugen M, Rosenlund G, Frøyland L, Arnesen H (2005)
Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis
Eur J Clin Invest, 35 (1), 52-9
DOI 10.1111/j.1365-2362.2005.01443.x, PubMed 15638820

Tonstad S, Sundfør T, Seljeflot I (2005)
Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease
Am J Cardiol, 95 (10), 1187-91
DOI 10.1016/j.amjcard.2005.01.047, PubMed 15877991

Trøseid M, Lappegård KT, Mollnes TE, Arnesen H, Seljeflot I (2005)
Changes in serum levels of E-selectin correlate to improved glycaemic control and reduced obesity in subjects with the metabolic syndrome
Scand J Clin Lab Invest, 65 (4), 283-90
DOI 10.1080/00365510510013811, PubMed 16076683

Publications 2004

Biong AS, Müller H, Seljeflot I, Veierød MB, Pedersen JI (2004)
A comparison of the effects of cheese and butter on serum lipids, haemostatic variables and homocysteine
Br J Nutr, 92 (5), 791-7
DOI 10.1079/bjn20041257, PubMed 15533268

Eid HM, Arnesen H, Hjerkinn EM, Lyberg T, Seljeflot I (2004)
Relationship between obesity, smoking, and the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine
Metabolism, 53 (12), 1574-9
DOI 10.1016/j.metabol.2004.06.026, PubMed 15562402

Johansen O, Brekke M, Seljeflot I, Semb AG, Arnesen H (2004)
Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty
Scand Cardiovasc J, 38 (4), 211-5
DOI 10.1080/14017430410035494, PubMed 15553931

Johansen O, Brekke M, Seljeflot I, Semb AGP, Arnesen H (2004)
Blood platelet count and reactivity are associated with restenosis 6 months after coronary angioplasty
In Scandinavian cardiovascular journal, Taylor & Francis, Stockholm, 38(2004)4, S. 211-215
BIBSYS 051805693

Lindman AS, Pedersen JI, Arnesen H, Hjerkinn EM, Veierød MB, Prydz H, Seljeflot I (2004)
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease
Thromb Res, 113 (1), 57-65
DOI 10.1016/j.thromres.2004.02.001, PubMed 15081566

Lindman AS, Pedersen JI, Hjerkinn EM, Arnesen H, Veierød MB, Ellingsen I, Seljeflot I (2004)
The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene
Thromb Haemost, 91 (6), 1097-104
DOI 10.1160/TH03-12-0773, PubMed 15175795

Mansoor MA, Seljeflot I, Arnesen H, Knudsen A, Bates CJ, Mishra G, Larsen TW (2004)
Endothelial cell adhesion molecules in healthy adults during acute hyperhomocysteinemia and mild hypertriglyceridemia
Clin Biochem, 37 (5), 408-14
DOI 10.1016/j.clinbiochem.2004.01.003, PubMed 15087258

Pettersen AA, Seljeflot I, Abdelnoor M, Arnesen H (2004)
Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design
Scand Cardiovasc J, 38 (6), 353-6
DOI 10.1080/14017430410024324, PubMed 15804802

Seljeflot I, Hurlen M, Arnesen H (2004)
Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction
J Thromb Haemost, 2 (5), 726-30
DOI 10.1111/j.1538-7836.2004.00676.x, PubMed 15099277

Seljeflot I, Hurlen M, Solheim S, Arnesen H (2004)
Serum levels of interleukin-10 are inversely related to future events in patients with acute myocardial infarction
J Thromb Haemost, 2 (2), 350-2
DOI 10.1111/j.1538-7933.2004.0584c.x, PubMed 14996010

Seljeflot I, Lyberg T, Arnesen H (2004)
Soluble tissue factor in plasma from patients with acute myocardial infarction is not microvesicle-associated
PROCEEDINGS OF THE 18TH INTERNATIONAL CONGRESS ON THROMBOSIS, 11-15

Aas AM, Birkeland KI, Seljeflot I (2004)
Effects of lifestyle intervention and insulin treatment on PAI-1, Hs-CRP and TNF-alfa levels in patients with Type 2 diabetes
In Diabetologia, Springer, Berlin, 47(2004)S1, S. A295 Abstrakt nr 818
BIBSYS 052055523

Publications 2003

Arnesen H, Dahl OE, Aspelin T, Seljeflot I, Kierulf P, Lyberg T (2003)
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin
J Thromb Haemost, 1 (5), 971-5
DOI 10.1046/j.1538-7836.2003.00111.x, PubMed 12871363

Berstad P, Seljeflot I, Veierød MB, Hjerkinn EM, Arnesen H, Pedersen JI (2003)
Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1
Clin Sci (Lond), 105 (1), 13-20
DOI 10.1042/CS20020349, PubMed 12589702

Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I (2003)
Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin
Atherosclerosis, 166 (2), 279-84
DOI 10.1016/s0021-9150(02)00206-x, PubMed 12535740

Kilhovd BK, Hjerkinn EM, Seljeflot I, Reikvam AA (2003)
Angiotensin-converting enzyme inhibition influences serumlevels of advanced glycation end products in patients with coronary heart disease: results from a HOPE substudy
In HeartDrug : excellence in cardiovascular trials, Karger, Basel, 3(2003)2, s.67-72
BIBSYS 041719298

Lindman AS, Müller H, Seljeflot I, Prydz H, Veierød M, Pedersen JI (2003)
Effects of dietary fat quantity and composition on fasting and postprandial levels of coagulation factor VII and serum choline-containing phospholipids
Br J Nutr, 90 (2), 329-36
DOI 10.1079/bjn2003911, PubMed 12908893

Müller H, Lindman AS, Blomfeldt A, Seljeflot I, Pedersen JI (2003)
A diet rich in coconut oil reduces diurnal postprandial variations in circulating tissue plasminogen activator antigen and fasting lipoprotein (a) compared with a diet rich in unsaturated fat in women
J Nutr, 133 (11), 3422-7
DOI 10.1093/jn/133.11.3422, PubMed 14608053

Seljeflot I, Hurlen M, Hole T, Arnesen H (2003)
Soluble tissue factor as predictor of future events in patients with acute myocardial infarction
Thromb Res, 111 (6), 369-72
DOI 10.1016/j.thromres.2003.09.019, PubMed 14698655

Solheim S, Arnesen H, Eikvar L, Hurlen M, Seljeflot I (2003)
Influence of aspirin on inflammatory markers in patients after acute myocardial infarction
Am J Cardiol, 92 (7), 843-5
DOI 10.1016/s0002-9149(03)00897-x, PubMed 14516890

Publications 2002

Andersen K, Hurlen M, Arnesen H, Seljeflot I (2002)
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease
Thromb Res, 108 (1), 37-42
DOI 10.1016/s0049-3848(02)00405-x, PubMed 12586130

Apeland T, Mansoor MA, Pentieva K, McNulty H, Seljeflot I, Strandjord RE (2002)
The effect of B-vitamins on hyperhomocysteinemia in patients on antiepileptic drugs
Epilepsy Res, 51 (3), 237-47
DOI 10.1016/s0920-1211(02)00153-5, PubMed 12399074

Apeland T, Mansoor MA, Seljeflot I, Brønstad I, Gøransson L, Strandjord RE (2002)
Homocysteine, malondialdehyde and endothelial markers in dialysis patients during low-dose folinic acid therapy
J Intern Med, 252 (5), 456-64
DOI 10.1046/j.1365-2796.2002.01056.x, PubMed 12528764

Eid HM, Lyberg T, Larsen J, Arnesen H, Seljeflot I (2002)
Reactive oxygen species generation by leukocytes in populations at risk for atherosclerotic disease
Scand J Clin Lab Invest, 62 (6), 431-9
DOI 10.1080/00365510260389985, PubMed 12469898

Olesen M, Kwong E, Meztli A, Kontny F, Seljeflot I, Arnesen H, Lyngdorf L, Falk E (2002)
No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice
Scand Cardiovasc J, 36 (6), 362-7
DOI 10.1080/140174302762659094, PubMed 12626204

Os I, Djurovic S, Seljeflot I, Berg K (2002)
Transforming growth factor (TGF)-beta1 inversely related to vascular cell adhesion molecule-1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF-beta1?
J Intern Med, 251 (3), 223-7
DOI 10.1046/j.1365-2796.2002.00950.x, PubMed 11886481

Os I, Os A, Sandset PM, Bølling S, Seljeflot I, Djurovic S, Westheim A (2002)
Hormone replacement therapy does not affect plasma homocysteine in postmenopausal women with coronary artery disease. Free tissue factor pathway inhibitor antigen, a circulating anticoagulant, is related to plasma homocysteine
Cardiology, 98 (1-2), 6-12
DOI 10.1159/000064667, PubMed 12373040

Schumacher A, Seljeflot I, Lerkerød AB, Sommervoll L, Otterstad JE, Arnesen H (2002)
Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease
Atherosclerosis, 164 (1), 153-60
DOI 10.1016/s0021-9150(02)00043-6, PubMed 12119204

Schumacher A, Seljeflot I, Lerkerød AB, Sommervoll L, Otterstad JE, Arnesen H (2002)
Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?
Clin Microbiol Infect, 8 (10), 654-61
DOI 10.1046/j.1469-0691.2002.00439.x, PubMed 12390284

Schumacher A, Seljeflot I, Sommervoll L, Christensen B, Otterstad JE, Arnesen H (2002)
Increased levels of endothelial haemostatic markers in patients with coronary heart disease
Thromb Res, 105 (1), 25-31
DOI 10.1016/s0049-3848(01)00399-1, PubMed 11864703

Schumacher A, Seljeflot I, Sommervoll L, Christensen B, Otterstad JE, Arnesen H (2002)
Increased levels of markers of vascular inflammation in patients with coronary heart disease
Scand J Clin Lab Invest, 62 (1), 59-68
DOI 10.1080/003655102753517217, PubMed 12002414

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease
Atherosclerosis, 162 (1), 179-85
DOI 10.1016/s0021-9150(01)00696-7, PubMed 11947912

Seljeflot I, Tonstad S, Hjermann I, Arnesen H (2002)
Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease
Thromb Res, 105 (4), 285-90
DOI 10.1016/s0049-3848(02)00034-8, PubMed 12031821

Yli-Jama P, Seljeflot I, Meyer HE, Hjerkinn EM, Arnesen H, Pedersen JI (2002)
Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction
Atherosclerosis, 164 (2), 275-81
DOI 10.1016/s0021-9150(02)00067-9, PubMed 12204798

Publications 2001

Guzic-Salobir B, Keber I, Seljeflot I, Arnesen H, Vrabic L (2001)
Combined hormone replacement therapy improves endothelial function in healthy postmenopausal women
J Intern Med, 250 (6), 508-15
DOI 10.1046/j.1365-2796.2001.00910.x, PubMed 11902819

Hurlen M, Hole T, Seljeflot I, Arnesen H (2001)
Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction
Eur J Heart Fail, 3 (2), 203-7
DOI 10.1016/s1388-9842(00)00138-0, PubMed 11246058

Johansen O, Abdelnoor M, Brekke M, Seljeflot I, Høstmark AT, Arnesen H (2001)
Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables
Scand Cardiovasc J, 35 (2), 86-91
DOI 10.1080/140174301750164691, PubMed 11405502

Kilhovd B, Hjerkinn EM, Seljeflot I, Berg TJ, Reikvam AA (2001)
The ACE inhibitor ramipril influences the serum levels ofadvanced glycation endproducts in high risk patients with coronary artery disease: results from a HOPE substudy
In European heart journal, Supplements, Saunders, London, 22(2001)Abstr. suppl, s.27 Abstrakt nr 243
BIBSYS 022034269

Kilhovd B, Hjerkinn EM, Seljeflot I, Berg TJ, Reikvam Å (2001)
Increase in serum levels of advanced glycation endproducts in high risk coronary artery disease patients is modified by the ace inhibitor ramipril
In Diabetologia, Springer, Berlin, 44(2001)suppl 1, s.A319 Abstrakt nr 1226
BIBSYS 02203529x

Müller H, Seljeflot I, Solvoll K, Pedersen JI (2001)
Partially hydrogenated soybean oil reduces postprandial t-PA activity compared with palm oil
Atherosclerosis, 155 (2), 467-76
DOI 10.1016/s0021-9150(00)00591-8, PubMed 11254919

Schumacher A, Lerkerød AB, Seljeflot I, Sommervoll L, Holme I, Otterstad JE, Arnesen H (2001)
Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals
J Clin Microbiol, 39 (5), 1859-64
DOI 10.1128/JCM.39.5.1859-1864.2001, PubMed 11326004

Solheim S, Seljeflot I, Arnesen H, Eritsland J, Eikvar L (2001)
Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks
Atherosclerosis, 157 (2), 411-5
DOI 10.1016/s0021-9150(00)00725-5, PubMed 11472741

Publications 2000

Hoibraaten E, Os I, Seljeflot I, Andersen TO, Hofstad A, Sandset PM (2000)
The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in women with atherosclerosis study
Thromb Res, 98 (1), 19-27
DOI 10.1016/s0049-3848(99)00233-9, PubMed 10706930

Hurlen M, Seljeflot I, Arnesen H (2000)
Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin
Thromb Res, 99 (5), 487-94
DOI 10.1016/s0049-3848(00)00277-2, PubMed 10973679

Seljeflot I, Arnesen H, Hofstad AE, Os I (2000)
Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease
Thromb Haemost, 83 (6), 944-8
PubMed 10896253

Publications 1999

Brude IR, Finstad HS, Seljeflot I, Drevon CA, Solvoll K, Sandstad B, Hjermann I, Arnesen H, Nenseter MS (1999)
Plasma homocysteine concentration related to diet, endothelial function and mononuclear cell gene expression among male hyperlipidaemic smokers
Eur J Clin Invest, 29 (2), 100-8
DOI 10.1046/j.1365-2362.1999.00419.x, PubMed 10092996

Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H (1999)
N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial
J Am Coll Cardiol, 33 (6), 1619-26
DOI 10.1016/s0735-1097(99)00054-6, PubMed 10334433

Johansen O, Seljeflot I, Høstmark AT, Arnesen H (1999)
The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease
Arterioscler Thromb Vasc Biol, 19 (7), 1681-6
DOI 10.1161/01.atv.19.7.1681, PubMed 10397685

Seljeflot I, Arnesen H, Andersen P, Aspelin T, Kierulf P (1999)
Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men
J Cardiovasc Pharmacol, 34 (4), 584-8
DOI 10.1097/00005344-199910000-00016, PubMed 10511135

Seljeflot I, Johansen O, Arnesen H, Eggesbø JB, Westvik AB, Kierulf P (1999)
Procoagulant activity and cytokine expression in whole blood cultures from patients with atherosclerosis supplemented with omega-3 fatty acids
Thromb Haemost, 81 (4), 566-70
PubMed 10235440

Publications 1998

Andersen P, Seljeflot I, Herzog A, Arnesen H, Hjermann I, Holme I (1998)
Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men
J Cardiovasc Pharmacol, 31 (5), 677-83
DOI 10.1097/00005344-199805000-00005, PubMed 9593066

Hurlen M, Seljeflot I, Arnesen H (1998)
The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction
Scand Cardiovasc J, 32 (4), 233-7
DOI 10.1080/14017439850140021, PubMed 9802142

Johansen O, Brekke M, Strømme JH, Valen V, Seljeflot I, Skjaeggestad O, Arnesen H (1998)
Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements
Eur Heart J, 19 (1), 112-7
DOI 10.1053/euhj.1997.0732, PubMed 9503183

Müller H, Jordal O, Seljeflot I, Kierulf P, Kirkhus B, Ledsaak O, Pedersen JI (1998)
Effect on plasma lipids and lipoproteins of replacing partially hydrogenated fish oil with vegetable fat in margarine
Br J Nutr, 80 (3), 243-51
DOI 10.1017/S0007114598001299, PubMed 9875064

Seljeflot I, Arnesen H, Brude IR, Nenseter MS, Drevon CA, Hjermann I (1998)
Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers
Eur J Clin Invest, 28 (8), 629-35
DOI 10.1046/j.1365-2362.1998.00336.x, PubMed 9767357

Seljeflot I, Moan A, Aspelin T, Tønnessen T, Kjeldsen SE, Arnesen H (1998)
Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo
Metabolism, 47 (3), 292-6
DOI 10.1016/s0026-0495(98)90259-1, PubMed 9500565

Strømme JH, Johansen O, Brekke M, Seljeflot I, Arnesen H (1998)
Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I
Scand J Clin Lab Invest, 58 (8), 693-9
DOI 10.1080/00365519850186139, PubMed 10088207

Publications 1997

Brude IR, Drevon CA, Hjermann I, Seljeflot I, Lund-Katz S, Saarem K, Sandstad B, Solvoll K, Halvorsen B, Arnesen H, Nenseter MS (1997)
Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants
Arterioscler Thromb Vasc Biol, 17 (11), 2576-88
DOI 10.1161/01.atv.17.11.2576, PubMed 9409230

Publications 1996

Almendingen K, Seljeflot I, Sandstad B, Pedersen JI (1996)
Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on hemostatic variables in men
Arterioscler Thromb Vasc Biol, 16 (3), 375-80
DOI 10.1161/01.atv.16.3.375, PubMed 8630662

Moan A, Høieggen A, Seljeflot I, Risanger T, Arnesen H, Kjeldsen SE (1996)
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity
J Hypertens, 14 (9), 1093-7
DOI 10.1097/00004872-199609000-00008, PubMed 8986909

Seljeflot I (1996)
Studies on the fibrinolytic system: with special reference to laboratory methods for evaluation of global fibrinolysis, and to some regulatory mechanisms of t-PA and PAI-1
Research forum, Ullevål hospital, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 962399515, ISBN 82-91675-07-4

Seljeflot I, Moan A, Kjeldsen S, Sandvik E, Arnesen H (1996)
Effect of angiotensin II receptor blockade on fibrinolysis during acute hyperinsulinemia in patients with essential hypertension
Hypertension, 27 (6), 1299-304
DOI 10.1161/01.hyp.27.6.1299, PubMed 8641739

Publications 1995

Andersen P, Seljeflot I, Abdelnoor M, Arnesen H, Dale PO, Løvik A, Birkeland K (1995)
Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome
Metabolism, 44 (5), 611-6
DOI 10.1016/0026-0495(95)90118-3, PubMed 7752909

Dahl OE, Aspelin T, Arnesen H, Seljeflot I, Kierulf P, Ruyter R, Lyberg T (1995)
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery
Thromb Res, 80 (4), 299-306
DOI 10.1016/0049-3848(95)00180-y, PubMed 8585042

Eritsland J, Arnesen H, Berg K, Seljeflot I, Abdelnoor M (1995)
Serum Lp(a) lipoprotein levels in patients with coronary artery disease and the influence of long-term n-3 fatty acid supplementation
Scand J Clin Lab Invest, 55 (4), 295-300
DOI 10.3109/00365519509104966, PubMed 7569731

Eritsland J, Arnesen H, Seljeflot I, Høstmark AT (1995)
Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease
Am J Clin Nutr, 61 (4), 831-6
DOI 10.1093/ajcn/61.4.831, PubMed 7702027

Eritsland J, Arnesen H, Seljeflot I, Kierulf P (1995)
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease
Blood Coagul Fibrinolysis, 6 (1), 17-22
DOI 10.1097/00001721-199502000-00003, PubMed 7795149

Eritsland J, Gjønnes G, Sandset PM, Seljeflot I, Arnesen H (1995)
Activated protein C resistance and graft occlusion after coronary artery bypass surgery
Thromb Res, 79 (2), 223-6
DOI 10.1016/0049-3848(95)91526-q, PubMed 7676409

Eritsland J, Seljeflot I, Arnesen H, Westvik AB, Kierulf P (1995)
Effect of long-term, moderate-dose supplementation with omega-3 fatty acids on monocyte procoagulant activity and release of interleukin-6 in patients with coronary artery disease
Thromb Res, 77 (4), 337-46
DOI 10.1016/0049-3848(95)93837-p, PubMed 7740525

SELJEFLOT I, ARNESEN H, STOEN R, LYBERG T (1995)
EFFECTS OF INSULIN AND SOME VASOCONSTRICTORS ON THE SYNTHESIS AND RELEASE OF T-PA AND PAI-1 FROM CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS
Fibrinolysis, 9 (4), 253-257
DOI 10.1016/S0268-9499(08)80068-9

Publications 1994

Eritsland J, Arnesen H, Seljeflot I, Abdelnoor M, Grønseth K, Berg K, Malinow MR (1994)
Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting
Am J Cardiol, 74 (11), 1099-102
DOI 10.1016/0002-9149(94)90459-6, PubMed 7977066

ERITSLAND J, SELJEFLOT I, ABDELNOOR M, ARNESEN H (1994)
LONG-TERM INFLUENCE OF OMEGA-3-FATTY-ACIDS ON FIBRINOLYSIS, FIBRINOGEN, AND SERUM-LIPIDS
Fibrinolysis, 8 (2), 120-125
DOI 10.1016/S0268-9499(05)80029-3

Eritsland J, Seljeflot I, Abdelnoor M, Arnesen H, Torjesen PA (1994)
Long-term effects of n-3 fatty acids on serum lipids and glycaemic control
Scand J Clin Lab Invest, 54 (4), 273-80
DOI 10.3109/00365519409087522, PubMed 7939369

Seljeflot I, Eritsland J, Andersen P, Arnesen H (1994)
Global fibrinolytic capacity assessed by the serum D-dimer test. Correlation between basal and stimulated values
Thromb Res, 75 (2), 157-62
DOI 10.1016/0049-3848(94)90064-7, PubMed 7974389

Seljeflot I, Eritsland J, Torjesen P, Arnesen H (1994)
Insulin and PAI-1 levels during oral glucose tolerance test in patients with coronary heart disease
Scand J Clin Lab Invest, 54 (3), 241-6
DOI 10.3109/00365519409088431, PubMed 8036449

Seljeflot I, Haaland AH, Arnesen H (1994)
Stability of plasma PAI-I at room temperature
Thromb Res, 73 (1), 75-8
DOI 10.1016/0049-3848(94)90056-6, PubMed 8178316

Publications 1993

Dahl OE, Pedersen T, Kierulf P, Westvik AB, Lund P, Arnesen H, Seljeflot I, Abdelnoor M, Lyberg T (1993)
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery
Thromb Res, 70 (6), 451-8
DOI 10.1016/0049-3848(93)90087-5, PubMed 8362370

SELJEFLOT I, ARNESEN H, ERITSLAND J, SMITH P (1993)
D-DIMER TEST AFTER STANDARDIZED COAGULATION - A NEW ASSAY FOR GLOBAL EVALUATION OF THE UNSTIMULATED FIBRINOLYTIC SYSTEM
Fibrinolysis, 7 (5), 303-307
DOI 10.1016/0268-9499(93)90145-L

Publications 1992

Eritsland J, Seljeflot I, Arnesen H, Smith P, Westvik AB (1992)
Effects of long-term treatment with warfarin on fibrinogen, FPA, TAT, and D-dimer in patients with coronary artery disease
Thromb Res, 66 (1), 55-60
DOI 10.1016/0049-3848(92)90155-4, PubMed 1412183

Publications 1990

Andersen P, Smith P, Seljeflot I, Brataker S, Arnesen H (1990)
Effects of gemfibrozil on lipids and haemostasis after myocardial infarction
Thromb Haemost, 63 (2), 174-7
PubMed 2194314

SELJEFLOT I, ARNESEN H, SMITH P, ANDERSEN P (1990)
D-DIMER AGGLUTINATION-TEST IN THE EVALUATION OF FIBRINOLYTIC CAPACITY AFTER STIMULATION WITH DDAVP
Fibrinolysis, 4 (2), 125-126
DOI 10.1016/0268-9499(90)90008-8

Smith P, Seljeflot I, Opstad T (1990)
Withdrawal of chronic beta-adrenoceptorblockade: effects on haemodynamics, blood lipids and haemostatic variables
Eur J Clin Pharmacol, 39 (1), 81-2
DOI 10.1007/BF02657064, PubMed 1980463

Publications 1989

Eritsland J, Arnesen H, Smith P, Seljeflot I, Dahl K (1989)
Effects of highly concentrated omega-3 polyunsaturated fatty acids and acetylsalicylic acid, alone and combined, on bleeding time and serum lipid profile
J Oslo City Hosp, 39 (8-9), 97-101
PubMed 2809856

Publications 1987

Arnesen H, Engebretsen LF, Ugland OM, Seljeflot I, Kierulf P (1987)
Increased fibrinolytic activity after surgery induced by low dose heparin
Thromb Res, 45 (5), 553-9
DOI 10.1016/0049-3848(87)90318-5, PubMed 3109060